Matthew J. Reilley

Statistics

Publications

Citations

1.1K

H-Index

Active since

2010

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of Virginia

University of Virginia Health System

University of Virginia Cancer Center

Sarah Cannon

Matthew J. Reilley is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, cancer immunotherapy, and immunotherapy.

ORCID

Publications per year

2010–2025

Publications

STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial

Matthew J. Reilley, Patricia McCoon, Carl Cook et al. · Journal for ImmunoTherapy of Cancer · 2018 · 288 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity

Casey R. Ager, Matthew J. Reilley, Courtney Nicholas et al. · Cancer Immunology Research · 2017 · 176 citations · Full text

Medicine, Immunology, Oncology +17

Activation of 4-1BB on Liver Myeloid Cells Triggers Hepatitis via an Interleukin-27–Dependent Pathway

Todd Bartkowiak, Ashvin R. Jaiswal, Casey R. Ager et al. · Clinical Cancer Research · 2018 · 102 citations · Full text

Life Sciences, Immunology, Oncology +16

Stoichiometry of STAT3 and Mitochondrial Proteins

Darci J. Phillips, Matthew J. Reilley, Angel Aponte et al. · Journal of Biological Chemistry · 2010 · 94 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma

Matthew J. Reilley, Brittany Morrow, Casey R. Ager et al. · Journal for ImmunoTherapy of Cancer · 2019 · 79 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 23